Early postoperative anticoagulation after mechanical valve replacement: A systematic review

Annals of Thoracic Surgery

Volumn 81, Issue 2, 2006, Pages 770-781

  Kulik, Alexander ^b   Rubens, Fraser D ^b   Wells, Philip S ^b   Kearon, Clive ^b   Mesana, Thierry G ^b   Van Berkom, Judith ^b   Lam, B Khanh ^a  

^a UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; CLOPIDOGREL; DEXTRAN; DIPYRIDAMOLE; ENOXAPARIN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; NADROPARIN; WARFARIN;

ABDOMINAL BLEEDING; ANTICOAGULATION; BLEEDING; BLOOD FLOW; BRAIN HEMORRHAGE; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; DEEP VEIN THROMBOSIS; DRUG INDICATION; GASTROINTESTINAL HEMORRHAGE; HEART ARRHYTHMIA; HEART TAMPONADE; HEART VALVE REPLACEMENT; HEMODYNAMICS; HEMOPERICARDIUM; HUMAN; INCIDENCE; LONGEVITY; META ANALYSIS; MORTALITY; NONHUMAN; PATHOGENESIS; PERIOPERATIVE PERIOD; PLEURA EFFUSION; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; RISK ASSESSMENT; RISK FACTOR; SYSTEMATIC REVIEW; THROMBOEMBOLISM; THROMBOGENESIS; THROMBOGENICITY;

ADMINISTRATION, ORAL; ANTICOAGULANTS; DRUG THERAPY, COMBINATION; HEART VALVE PROSTHESIS IMPLANTATION; HEMORRHAGE; HEPARIN; HUMANS; PLATELET AGGREGATION INHIBITORS; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; RISK FACTORS; THROMBOEMBOLISM; WARFARIN;

EID: 31044435761     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2005.07.023     Document Type: Review

References (79)

1. J.H. Chesebro, P.C. Adams, V. Fuster Antithrombotic therapy in patients with valvular heart disease and prosthetic heart valves J Am Coll Cardiol 8 suppl B 1986 41B 56B
2. L.H. Edmunds Jr Thrombotic and bleeding complications of prosthetic heart valves Ann Thorac Surg 44 1987 430 445
3. C. Kearon Management of anticoagulation in patients who require invasive procedures Semin Vasc Med 3 2003 285 294
4. L.H. Edmunds Jr, R.E. Clark, L.H. Cohn, G.L. Grunkemeier, D.C. Miller, R.D. Weisel Guidelines for reporting morbidity and mortality after cardiac valvular operations J Thorac Cardiovasc Surg 112 1996 708 711
5. W. Ageno, A.G. Turpie, L. Steidl Comparison of a daily fixed 2.5-mg warfarin dose with a 5-mg, international normalized ratio adjusted, warfarin dose initially following heart valve replacement Am J Cardiol 88 2001 40 44
6. G. Montalescot, V. Polle, J.P. Collet Low molecular weight heparin after mechanical heart valve replacement Circulation 101 2000 1083 1086
7. J. Acar, B. Iung, J.P. Boissel AREVA multicenter randomized comparison of low-dose versus standard-dose anticoagulation in patients with mechanical prosthetic heart valves Circulation 94 1996 2107 2112
8. J. Fanikos, K. Tsilimingras, N. Kucher, A.B. Rosen, M.D. Hieblinger, S.Z. Goldhaber Comparison of efficacy, safety, and cost of low-molecular-weight heparin with continuous-infusion unfractionated heparin for initiation of anticoagulation after mechanical prosthetic valve implantation Am J Cardiol 93 2004 247 250
9. L. Iliuta, V. Candea, A. Vasilescu, H. Moldovan, D.P. Gherghiceanu, C. Macarie Fraxiparine versus unfractionated heparin for the perioperative anticoagulant therapy in patients undergoing mechanical prosthetic heart valve replacement Archives de L'Union Medicale Balkanique 38 2003 141 148
10. M.K. Dewanjee, V.F. Trastek, M. Tago, M.P. Kaye Radioisotopic techniques for noninvasive detection of platelet deposition in bovine-tissue mitral-valve prostheses and in vitro quantification of visceral microembolism in dogs Invest Radiol 19 1984 535 542
11. L.A. Harker, S.J. Slichter Studies of platelet and fibrinogen kinetics in patients with prosthetic heart valves N Engl J Med 283 1970 1302 1305
12. B. Stein, V. Fuster, J.L. Halperin, J.H. Chesebro Antithrombotic therapy in cardiac disease. An emerging approach based on pathogenesis and risk Circulation 80 1989 1501 1513
13. Y. Nemerson, V.T. Turitto The effect of flow on hemostasis and thrombosis Thromb Haemost 66 1991 272 276
14. V. Pengo, P. Peruzzi, M. Baca The optimal therapeutic range for oral anticoagulant treatment as suggested by fibrinopeptide A (FpA) levels in patients with heart valve prostheses Eur J Clin Invest 19 1989 181 184
15. P.S. Douglas, J.W. Hirshfeld Jr, R.N. Edie, A.H. Harken, L.W. Stephenson, L.H. Edmunds Jr Clinical comparison of St. Jude and porcine aortic valve prostheses Circulation 72 pt 2 1985 II135 II139
16. D.A. Murphy, F.H. Levine, M.J. Buckley Mechanical valves a comparative analysis of the Starr-Edwards and Bjork-Shiley prostheses J Thorac Cardiovasc Surg 86 1983 746 752
17. E.G. Butchart, P.A. Lewis, E.N. Kulatilake, I.M. Breckenridge Anticoagulation variability between centres implications for comparative prosthetic valve assessment Eur J Cardiothorac Surg 2 1988 72 81
18. E.G. Butchart, P.A. Lewis, J.A. Bethel, I.M. Breckenridge Adjusting anticoagulation to prosthesis thrombogenicity and patient risk factors. Recommendations for the Medtronic Hall valve Circulation 84 suppl 1991 III61 III69
19. M. Heras, J.H. Chesebro, V. Fuster High risk of thromboemboli early after bioprosthetic cardiac valve replacement J Am Coll Cardiol 25 1995 1111 1119
20. M. Brais, N.S. Braunwald Acceleration of tissue ingrowth on materials implanted in the heart Ann Thorac Surg 21 1976 221 229
21. B. Bull, N.S. Braunwald Human histopathologic response to a completely fabric-covered prosthetic heart valve Ann Surg 174 1971 755 761
22. J.N. Saour, J.O. Sieck, L.A. Mamo, A.S. Gallus Trial of different intensities of anticoagulation in patients with prosthetic heart valves N Engl J Med 322 1990 428 432
23. C.K. Mok, J. Boey, R. Wang Warfarin versus dipyridamole-aspirin and pentoxifylline-aspirin for the prevention of prosthetic heart valve thromboembolism a prospective randomized clinical trial Circulation 72 1985 1059 1063
24. S.C. Cannegieter, F.R. Rosendaal, E. Briet Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses Circulation 89 1994 635 641
25. J. Hirsh, J.E. Dalen, D.R. Anderson Oral anticoagulants mechanism of action, clinical effectiveness, and optimal therapeutic range Chest 114 suppl 5 1998 445S 469S
26. P.D. Stein, J.S. Alpert, H.I. Bussey, J.E. Dalen, A.G. Turpie Antithrombotic therapy in patients with mechanical and biological prosthetic heart valves Chest 119 suppl 1 2001 220S 227S
27. R.O. Bonow, B. Carabello, A.C. de Leon Jr Guidelines for the management of patients with valvular heart disease: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients with Valvular Heart Disease) ?? Circulation 98 1998 1949 1984
28. P.A. Ribeiro, M. Al Zaibag, M. Idris Antiplatelet drugs and the incidence of thromboembolic complications of the St. Jude Medical aortic prosthesis in patients with rheumatic heart disease J Thorac Cardiovasc Surg 91 1986 92 98
29. L.S. Czer, J.M. Matloff, A. Chaux, M. De Robertis, M.E. Stewart, R.J. Gray The St. Jude valve analysis of thromboembolism, warfarin-related hemorrhage, and survival Am Heart J 114 1987 389 397
30. A. Schlitt, R.S. von Bardeleben, A. Ehrlich Clopidogrel and aspirin in the prevention of thromboembolic complications after mechanical aortic valve replacement (CAPTA) Thromb Res 109 2-3 2003 131 135
31. P. Laffort, R. Roudaut, X. Roques Early and long-term (one-year) effects of the association of aspirin and oral anticoagulant on thrombi and morbidity after replacement of the mitral valve with the St. Jude medical prosthesis a clinical and transesophageal echocardiographic study J Am Coll Cardiol 35 2000 739 746
32. D. Massel, S.H. Little Risks and benefits of adding anti-platelet therapy to warfarin among patients with prosthetic heart valves a meta-analysis J Am Coll Cardiol 37 2001 569 578
33. J.C. Cappelleri, L.D. Fiore, M.T. Brophy, D. Deykin, J. Lau Efficacy and safety of combined anticoagulant and antiplatelet therapy versus anticoagulant monotherapy after mechanical heart-valve replacement a metaanalysis Am Heart J 130 pt 1 1995 547 552
34. J.G. Ray, A.G. Turpie Survey of cardiac surgeons' perceptions of the addition of ASA to warfarin for patients with mechanical heart valves Can J Cardiol 13 1997 1162 1165
35. M.N. Levine, G. Raskob, S. Landefeld, C. Kearon Hemorrhagic complications of anticoagulant treatment Chest 119 suppl 1 2001 108S 121S
36. E.W. Muriithi, P.R. Belcher, S.P. Day, V.C. Menys, D.J. Wheatley Heparin-induced platelet dysfunction and cardiopulmonary bypass Ann Thorac Surg 69 2000 1827 1832
37. J.F. Malouf, S. Alam, W. Gharzeddine, M.A. Stefadouros The role of anticoagulation in the development of pericardial effusion and late tamponade after cardiac surgery Eur Heart J 14 1993 1451 1457
38. M. Pepi, M. Muratori, P. Barbier Pericardial effusion after cardiac surgery incidence, site, size, and haemodynamic consequences Br Heart J 72 1994 327 331
39. A.A. Mangi, I.F. Palacios, D.F. Torchiana Catheter pericardiocentesis for delayed tamponade after cardiac valve operation Ann Thorac Surg 73 2002 1479 1483
40. P. Meurin, H. Weber, N. Renaud Evolution of the postoperative pericardial effusion after day 15 the problem of the late tamponade Chest 125 2004 2182 2187
41. M.J. Unsworth-White, A. Herriot, O. Valencia Resternotomy for bleeding after cardiac operation a marker for increased morbidity and mortality Ann Thorac Surg 59 1995 664 667
42. C.S. Landefeld, L. Goldman Major bleeding in outpatients treated with warfarin incidence and prediction by factors known at the start of outpatient therapy Am J Med 87 1989 144 152
43. F.J. van der Meer, F.R. Rosendaal, J.P. Vandenbroucke, E. Briet Bleeding complications in oral anticoagulant therapy. An analysis of risk factors Arch Intern Med 153 1993 1557 1562
44. P.H. van der Voort, D.F. Zandstra Pathogenesis, risk factors, and incidence of upper gastrointestinal bleeding after cardiac surgery is specific prophylaxis in routine bypass procedures needed? J Cardiothorac Vasc Anesth 14 2000 293 299
45. G.H. Sakorafas, G.G. Tsiotos Intra-abdominal complications after cardiac surgery Eur J Surg 165 1999 820 827
46. L.O. Heikkinen, K.V. Ala-Kulju Abdominal complications following cardiopulmonary bypass in open-heart surgery Scand J Thorac Cardiovasc Surg 21 1987 1 7
47. J. Hirsh, R. Raschke Heparin and low-molecular-weight heparin the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy Chest 126 suppl 3 2004 188S 203S
48. J.H. Chesebro, V. Fuster Optimal antithrombotic therapy for mechanical prosthetic heart valves Circulation 94 1996 2055 2056
49. M. Wilhelm, T. Carrel, R. Jenni, M. Turina Incidence, clinical aspects and therapy of late pericardial tamponade following heart surgery Swiss Surg 3 1996 92 96
50. M.C. Malergue, J. Temkine, M. Slama Value of early systematic postoperative transesophageal echocardiography in mitral valve replacements. A prospective study of 50 patients Arch Mal Coeur Vaiss 85 1992 1299 1304
51. J.F. Grehan, S.L. Hilbert, V.J. Ferrans, J.S. Droel, C.T. Salerno, R.W. Bianco Development and evaluation of a swine model to assess the preclinical safety of mechanical heart valves J Heart Valve Dis 9 2000 710 719 discussion 719-20
52. L.I. Thulin, C.L. Olin Initiation and long-term anticoagulation after heart valve replacements Arq Bras Cardiol 49 1987 265 268
53. J.S. Ginsberg Management of venous thromboembolism N Engl J Med 335 1996 1816 1828
54. British Society for Haematology annual scientific meeting Glasgow, United Kingdom, 27-30 April 1998. Proceedings and abstracts Br J Haematol 101 suppl 1 1998 1 115
55. T.E. Warkentin, M.N. Levine, J. Hirsh Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin N Engl J Med 332 1995 1330 1335
56. J.I. Weitz Low-molecular-weight heparins N Engl J Med 337 1997 688 698
57. D.R. Anderson, B.J. O'Brien, M.N. Levine, R. Roberts, P.S. Wells, J. Hirsh Efficacy and cost of low-molecular-weight heparin compared with standard heparin for the prevention of deep vein thrombosis after total hip arthroplasty Ann Intern Med 119 1993 1105 1112
58. Anon. Home LMWH bridge therapy in cardiac replacement: safe, effective, and cost-saving Formulary 35 2000 990 991
59. C.W. Akins Long-term results with the Medtronic-Hall valvular prosthesis Ann Thorac Surg 61 1996 806 813
60. V. Anttila, J. Heikkinen, F. Biancari A retrospective comparative study of aortic valve replacement with St. Jude medical and medtronic-hall prostheses a 20-year follow-up study Scand Cardiovasc J 36 2002 53 59
61. J.M. Bernal, J.M. Rabasa, F. Gutierrez-Garcia, C. Morales, J.F. Nistal, J.M. Revuelta The CarboMedics valve experience with 1,049 implants Ann Thorac Surg 65 1998 137 143
62. M.J. Dalrymple-Hay, R.K. Pearce, S. Dawkins Mid-term results with 1,503 CarboMedics mechanical valve implants J Heart Valve Dis 9 3 2000 389 395
63. A. de la Fuente, R. Sanchez, J. Romero CarboMedics and Monostrut valves clinical and hemodynamic outcomes in a randomized study J Heart Valve Dis 9 2000 303 307
64. M. Demirag, K. Kirali, S.N. Omeroglu Mechanical versus biological valve prosthesis in the mitral position a 10-year follow up of St. Jude Medical and Biocor valves J Heart Valve Dis 10 2001 78 83
65. D. Duveau, J.L. Michaud, P. Despins Mitral valve replacement with St Jude Medical prosthesis. Incidence of thromboembolic events in 349 patients Eur Heart J 5 suppl D 1984 49 52
66. R.W. Emery, G.J. Van Nooten, P.J. Tesar The initial experience with the ATS Medical mechanical cardiac valve prosthesis Ann Thorac Surg 75 2003 444 452
67. A.E. Fiane, O.R. Geiran, J.L. Svennevig Up to eight years' follow-up of 997 patients receiving the CarboMedics prosthetic heart valve Ann Thorac Surg 66 1998 443 448
68. Y. Iguro, Y. Moriyama, A. Yamaoka Clinical experience of 473 patients with the omnicarbon prosthetic heart valve J Heart Valve Dis 8 1999 674 679
69. K.H. Lim, M. Caputo, R. Ascione Prospective randomized comparison of CarboMedics and St Jude Medical bileaflet mechanical heart valve prostheses an interim report J Thorac Cardiovasc Surg 123 2002 21 32
70. R.G. Masters, A.L. Pipe, V.M. Walley, W.J. Keon Comparative results with the St. Jude Medical and Medtronic Hall mechanical valves J Thorac Cardiovasc Surg 110 1995 663 671
71. K. Minakata, Y. Wu, K.J. Zerr Clinical evaluation of the carbomedics prosthesis experience at providence health system in Portland J Heart Valve Dis 11 2002 844 850
72. D.M. Nicoloff, R.W. Emery, K.V. Arom Clinical and hemodynamic results with the St. Jude Medical cardiac valve prosthesis. A three-year experience J Thorac Cardiovasc Surg 82 1981 674 683
73. J.F. Nistal, A. Hurle, J.M. Revuelta, M. Gandarillas Clinical experience with the CarboMedics valve early results with a new bileaflet mechanical prosthesis J Thorac Cardiovasc Surg 112 1996 59 68
74. S.M. Rodler, A. Moritz, W. Schreiner, A. End, P. Dubsky, E. Wolner Five-year follow-up after heart valve replacement with the CarboMedics bileaflet prosthesis Ann Thorac Surg 63 1997 1018 1025
75. F. Santini, G. Casali, F. Viscardi The CarboMedics prosthetic heart valve experience with 1,084 implants J Heart Valve Dis 11 2002 121 126 discussion 27
76. B. Yamak, H.Y. Karagoz, Y. Zorlutuna, A. Eralp, O. Tasdemir, K. Bayazit Low-dose anticoagulant management of patients with St. Jude Medical mechanical valve prostheses Thorac Cardiovasc Surg 41 1993 38 42
77. S. Aoyagi, A. Oryoji, Y. Nishi, K. Tanaka, K. Kosuga, K. Oishi Long-term results of valve replacement with the St. Jude Medical valve J Thorac Cardiovasc Surg 108 1994 1021 1029
78. E.M. Baudet, V. Puel, J.T. McBride Long-term results of valve replacement with the St. Jude Medical prosthesis J Thorac Cardiovasc Surg 109 1995 858 870
79. L.F. Camilleri, P. Bailly, B.J. Legault, B. Miguel, M.C. D'Agrosa-Boiteux, C.M. de Riberolles Mitral and mitro-aortic valve replacement with Sorin Bicarbon valves compared with St. Jude medical valves Cardiovasc Surg 9 2001 272 280